Literature DB >> 20861714

Haemophilus paraphrophilus peritonitis followed by tuberculous peritonitis and Pott's disease.

DuChu Wu1, Badri Giri.   

Abstract

Patients with alcoholic cirrhosis who have ascites have a high risk of developing spontaneous bacterial peritonitis (SBP). The authors report a case of SBP caused by Haemophilus paraphrophilus, the first-reported SBP in literature with this pathogen. Later on, the patient also developed tuberculous (TB) peritonitis associated with thoracic Pott's disease, a combination never reported before. The diagnoses were confirmed by positive mycobacterium cultures of both omental tissues and vertebral tissues. This report also illustrates prominent computed tomography findings of TB peritonitis and magnetic resonance imaging of spinal cord compression of Pott's disease. Tuberculosis is a treatable and curable disease and should be considered as a potential offending pathogen on differential diagnosis in SBP of alcoholic cirrhotic patients. Timely biopsy and surgical intervention with these kinds of TB are needed to lead early diagnosis and result in an excellent outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20861714     DOI: 10.1097/MAJ.0b013e3181f0fd20

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Infective Endocarditis by Aggregatibacter paraphrophilus: Case Report and Literature Review.

Authors:  Smita Sood
Journal:  J Clin Diagn Res       Date:  2013-11-10

2.  Emergence of Haemophilus influenzae Strains in the Nasopharynx of Children with Tuberculosis.

Authors:  Alina V Martynova; Larisa A Balabanova; Alexei Pruschinskyi
Journal:  Pulm Med       Date:  2011-07-03

Review 3.  Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis.

Authors:  Yong-Tao Li; Jian-Rong Huang; Mei-Lian Peng
Journal:  Biomed Res Int       Date:  2020-07-06       Impact factor: 3.411

4.  A case of tuberculous peritonitis.

Authors:  Wenyi Niu; Mingying Li; Yonggan Wan; Helin Wang; Zhenxuan Wu; Junwei Cui
Journal:  Exp Ther Med       Date:  2012-09-20       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.